Norovirus vaccine study
Client Testimonial
This partnership reflects our shared commitment to advancing clinical research, fostering innovation, and improving participant outcomes. These Mobile Research Units are not just vehicles - they are catalysts for change, making research more accessible, inclusive, and impactful.
Moderna
Spokesperson
Improving access to vaccine research in rural communities
Mobile research unit supports norovirus vaccine study
EMS Healthcare has deployed a state-of-the-art mobile clinical trial unit to support the NOVA301 study in partnership with Royal Cornwall Hospitals NHS Trust (RCHT) and Layton Medical Centre GP practice in Blackpool.
Designed to improve access to research in remote and coastal areas, the unit is helping to bring follow-up care closer to home for participants in a phase 3 norovirus vaccine trial.
EMS Healthcare is proud to support this pilot initiative, taking clinical research beyond hospital walls. The study exemplifies how collaboration across the NHS, industry, and research networks can remove barriers to participation and improve outcomes for all.
Client Testimonial
The mobile research unit is a transformative step in overcoming geographical barriers to clinical research in Cornwall. By bringing research directly to communities - especially those in remote and rural areas - we are ensuring that everyone, regardless of location, has the opportunity to participate in advanced healthcare studies. This initiative is a vital step towards reducing health inequalities, improving patient outcomes, and positioning Cornwall as a leader in accessible, community-driven research.
Bianca Mills
Head of Research and Development, Royal Cornwall Hospitals NHS Trust
Reducing barriers to research
Supporting inclusion with community research sites
The NOVA301 trial is a national study led by Moderna, NIHR, and the UK Vaccine Innovation Pathway (VIP), investigating a new vaccine for norovirus. With over 3,000 participants recruited across 39 sites, the study is expanding access to cutting-edge research.
To support the trial, EMS Healthcare supplied two mobile research units equipped with an ultra-low temperature freezer, tabletop centrifuge, and high-quality clinical space. This enables full trial follow-up activities on board, helping reduce the burden of travel for participants in rural locations.
